Zobrazeno 1 - 10
of 731
pro vyhledávání: '"Wg. Jiang"'
Publikováno v:
British Journal of Surgery. 108
Introduction ALCAM (also known as CD166) is a membrane integral protein and said to have a role in predicting the clinical outcome of patients with breast cancer, but the pattern of the prediction value is inconsistent. ALCAM confers cell-cell adhesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58037c354910915cb2d0fdf4057b5aea
https://doi.org/10.1093/bjs/znab282.023
https://doi.org/10.1093/bjs/znab282.023
Publikováno v:
British Journal of Surgery. 108
Introduction Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a cell adhesion molecule and one of the potential metastasis ‘soil’ receptors that via homotypic and heterotypic interactions, mediates cell adhesion. The present study inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c082b81e494f8b9729d614940116b08e
https://doi.org/10.1093/bjs/znab282.016
https://doi.org/10.1093/bjs/znab282.016
Autor:
Z Tian, W Zhong, G Liang, Y Ling, Z Liu, L Tan, K Chen, WG Jiang, Andrew James Sanders, Y Wang, N You, C Gong
Publikováno v:
Cancer Research. 79:P2-07
Purpose The aim of the study was to develop a specific nomogram for prediction of prognosis for breast Paget's disease with infiltrating ductal carcinoma (PD-IDC) patients. Patients and Methods Patients data were obtained by the Surveillance, Epidemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12608a9dda80cc22658651365c670499
https://doi.org/10.1158/1538-7445.sabcs18-p2-07-12
https://doi.org/10.1158/1538-7445.sabcs18-p2-07-12
Publikováno v:
Cancer Research. 79:P6-09
Co-first author: W.T., G.L., X.X. * Co-Correspondence: C.G. and W.G.J. Abstract Background: Circulating tumor cells (CTCs) display changes in epithelial-mesenchymal transition (EMT) markers and miRNAs regulate EMT in breast cancer cells. The associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7f551552cccb180d2b1278496380ff1
https://doi.org/10.1158/1538-7445.sabcs18-p6-09-07
https://doi.org/10.1158/1538-7445.sabcs18-p6-09-07
Autor:
Andrew James Sanders, Fiona Ruge, Tracey Amanda Martin, G Gao, Wg. Jiang, Eleri Davies, Sioned Owen, Lin Ye, Yiling Wu, Cong Wei
Publikováno v:
Cancer Research. 78:P3-15
Background. Yangzheng Xiaoji is a formulation of Chinese medicine and has been used in the treatment of solid cancer as an adjuvant to chemotherapy by reducing the side effects to the patient. There has been evidence to show that the medicine has a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::137c5c2c82ea3370eff3af16ee14ea1c
https://doi.org/10.1158/1538-7445.sabcs17-p3-15-04
https://doi.org/10.1158/1538-7445.sabcs17-p3-15-04
Publikováno v:
Cancer Research. 78:P1-17
Background: Breast cancer patients who develop brain metastases have poor prognosis/short overall survival. Human epidermal growth factor receptor 2 (HER2) +ive breast cancer have an increased propensity for brain metastases. Currently, these metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a45e8136ea78833783477f84c599032
https://doi.org/10.1158/1538-7445.sabcs17-p1-17-07
https://doi.org/10.1158/1538-7445.sabcs17-p1-17-07
Publikováno v:
Cancer Research. 78:P3-06
Background. Triple negative breast cancer (TNBC) is a challenging both in the choice of therapies and clinical outcomes. In the present study, we investigated the potential prospect of a Chinese medicine formation, ShenLingLan, shown to have benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ff8dbf9876ee291f48b7962c9861ba
https://doi.org/10.1158/1538-7445.sabcs17-p3-06-10
https://doi.org/10.1158/1538-7445.sabcs17-p3-06-10
Autor:
Alshad S. Lalani, Sioned Owen, Fiona Ruge, Wg. Jiang, Eleri Davies, Francesca Avogadri-Connors, Richard Bryce
Publikováno v:
Cancer Research. 78:P3-07
Background. Neratinib is an orally available tyrosine kinase inhibitor that irreversibly binds and inhibits EGFR, HER2 and HER4 receptor tyrosine kinases. Neratinib has been shown to have clinical activity in HER2-amplified or overexpressed breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8dda545073e6fa140d74886f7baa4a8
https://doi.org/10.1158/1538-7445.sabcs17-p3-07-07
https://doi.org/10.1158/1538-7445.sabcs17-p3-07-07
Autor:
Kefah Mokbel, Sioned Owen, Eleri Davies, A. K. Sharma, Andrew James Sanders, Wg. Jiang, M Uhercik
Publikováno v:
Cancer Research. 78:P1-07
Background:The Mammalian Target of Rapamycin (mTOR) regulates a multitude of cellular processes including metabolism, proliferation and growth. It is known to form two multi-protein complexes - complex 1 (mTORC1) and complex 2 (mTORC2) with Raptor an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0f0ed54193752413c8174035a375f6b
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-27
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-27
Publikováno v:
Kemija u Industriji, Vol 64, Iss 3-4, Pp 117-124 (2015)
Textile composites consist of interlaced tows, which are impregnated with a matrix material and then cured. The interlacing of the tows offers the potential for increased through-thickness strength compared to conventional laminated composites. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690c4d27a715dc5543fe25fb70edcf8f
https://doi.org/10.15255/kui.2015.006
https://doi.org/10.15255/kui.2015.006